Division of Rheumatology, University of Washington, Seattle, WA, United States.
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Front Immunol. 2021 Jul 7;12:693192. doi: 10.3389/fimmu.2021.693192. eCollection 2021.
IgG4-related disease (IgG4-RD) is a rare systemic fibroinflammatory disease frequently associated with allergy. The pathogenesis of IgG4-RD is poorly understood, and effective therapies are limited. However, IgG4-RD appears to involve some of the same pathogenic mechanisms observed in allergic disease, such as T helper 2 (Th2) and regulatory T cell (Treg) activation, IgG4 and IgE hypersecretion, and blood/tissue eosinophilia. In addition, IgG4-RD tissue fibrosis appears to involve activation of basophils and mast cells and their release of alarmins and cytokines. In this article, we review allergy-like features of IgG4-RD and highlight targeted therapies for allergy that have potential in treating patients with IgG4-RD.
IgG4 相关疾病(IgG4-RD)是一种罕见的全身性纤维炎症性疾病,常与过敏有关。IgG4-RD 的发病机制尚不清楚,有效的治疗方法也有限。然而,IgG4-RD 似乎涉及到一些在过敏疾病中观察到的相同致病机制,例如辅助性 T 细胞 2(Th2)和调节性 T 细胞(Treg)的激活、IgG4 和 IgE 的过度分泌以及血液/组织嗜酸性粒细胞增多。此外,IgG4-RD 组织纤维化似乎涉及到嗜碱性粒细胞和肥大细胞的激活及其释放警报素和细胞因子。在本文中,我们回顾了 IgG4-RD 的类似过敏的特征,并强调了针对过敏的靶向治疗方法,这些方法有可能治疗 IgG4-RD 患者。